Fingolimod and Anaemia - a phase IV clinical study of FDA data

Summary:

Anaemia is reported as a side effect among people who take Fingolimod (fingolimod), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Gilenya, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Anaemia when taking Fingolimod. It is created by eHealthMe based on reports of 5,142 people who have side effects when taking Fingolimod from the FDA, and is updated regularly.

What is Fingolimod?

Fingolimod has active ingredients of fingolimod. eHealthMe is studying from 5,150 Fingolimod users. Check the latest studies of Fingolimod.

What is Anaemia?

Anaemia (lack of blood) is found to be associated with 3,028 drugs and 3,946 conditions by eHealthMe. Check the latest studies of Anaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

5,142 people reported to have side effects when taking Fingolimod.
Among them, 14 people (0.27%) have Anaemia.

Among these 14 people:

How long have people been on Fingolimod when they have Anaemia? *

What is the gender of people who have Anaemia when taking Fingolimod? *

female: 75 %
male: 25 %

What is the age of people who have Anaemia when taking Fingolimod? *

What are other drugs people take besides Fingolimod? *

What are other side effects people have besides Anaemia? *

Pain: 8 people, 57.14%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 50.00%
Acute Kidney Failure: 5 people, 35.71%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 28.57%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 28.57%
Thyroid Diseases: 4 people, 28.57%
Abdominal Discomfort: 4 people, 28.57%
Intraocular Pressure Increased: 4 people, 28.57%
Headache (pain in head): 3 people, 21.43%
Memory Loss: 3 people, 21.43%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 78.57%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 14.29%
Visual Impairment: 1 person, 7.14%
Urinary Tract Infection: 1 person, 7.14%
Urinary Tract Disorder: 1 person, 7.14%
Stress And Anxiety: 1 person, 7.14%
Gastric Disorder (disease of stomach): 1 person, 7.14%
Diabetes: 1 person, 7.14%
Cardiac Disorder: 1 person, 7.14%
Blood Pressure Abnormal: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Fingolimod and have Anaemia?

- Check whether Anaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fingolimod:

Fingolimod (5,150 reports)

Anaemia treatments and more:

Anaemia (269,298 reports)

Browse all side effects of Fingolimod:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Anaemia:

Anaemia (3,029 drugs)

Browse all the conditions that are associated with Anaemia:

Anaemia (3,946 conditions)

Related publications that referenced our studies

Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Alroughani R, "Fingolimod-associated amenorrhea: a report of three cases", Multiple Sclerosis Journal, 2014 Jan .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Alroughani R, "Fingolimod-associated amenorrhea: a report of three cases", Multiple Sclerosis Journal, 2014 Jan .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on fingolimod (the active ingredients of Fingolimod) and Fingolimod (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.